A “no-deal” Brexit could accelerate existing the supply chain trend of increased purchases from outside the EU. Pharmaceutical suppliers including Novo Nordisk and Sanofi have warned of shortages in the event of that a withdrawal agreement and related customs arrangements are not finalized. That may explain the turnaround in British imports of medicines to a 2.4% year over year rise after an average 13.2% decline in the prior three months. Over the longer term supplies of pharmaceuticals from outside the EU are already increasing. For example imports from India climbed 15.8% in the 12 mo...